Healthcare -
Biotechnology - NASDAQ - US
$ 10.86
3.23 %
$ 440 M
Market Cap
-2.08
P/E
KROS - OPERATING INCOME
Operating Income KROS - Keros Therapeutics, Inc.
-170 M
LAST VALUE
-73.63%
2 YEAR CAGR
-151.44%
5 YEAR CAGR
0.00%
10 YEAR CAGR